Recruiting Heart Attack Studies in Miramar
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG....
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
This is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of SAR441344 in comparison with placebo in the treatm...
About Heart Attack Clinical Trials in Miramar
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Miramar, FLORIDA. These studies are seeking a combined 916 participants. Research is being sponsored by Ionis Pharmaceuticals, Inc., Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Miramar — FAQ
Are there heart attack clinical trials in Miramar?
Yes, there are 2 heart attack clinical trials currently recruiting in Miramar, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miramar?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miramar research site will contact you about next steps.
Are clinical trials in Miramar free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miramar studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Miramar are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov